We developed and validated a deep learning system (termed DeepDR Plus) in a diverse, multiethnic, multi-country dataset to predict personalized risk and time to progression of diabetic retinopathy. We show that DeepDR Plus can be integrated into the clinical workflow to promote individualized intervention strategies for the management of diabetic retinopathy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wong, T. Y. et al. Diabetic retinopathy. Nat. Rev. Dis. Primers 2, 16012 (2016). A review article that discusses DR epidemiology, pathophysiology, diagnosis, and treatment options, as well as its effect on quality of life.
Stratton, I. M. et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44, 156–163 (2001). This paper reports the high variability in risk of DR progression and the need for good glycemic control and assiduous treatment of hypertension.
Bora, A. et al. Predicting the risk of developing diabetic retinopathy using deep learning. Lancet Digit. Health 3, e10–e19 (2021). This paper reports a deep learning system for predicting DR development from fundus images, which are independent of and more informative than available risk factors.
Liu, H. et al. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis. Lancet Glob. Health 11, e456–e465 (2023). This paper reports that AI coupled with teleophthalmology is cost-effective in both rural and urban China, which presents an opportunity to promote equity in eye health.
Rajpurkar, P. et al. AI in health and medicine. Nat. Med. 28, 31–38 (2022). A review article that presents the advances, challenges and potential in the field of medical AI.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Dai, L. et al. A deep learning system for predicting time to progression of diabetic retinopathy. Nat. Med. https://doi.org/10.1038/s41591-023-02702-z (2024).
Rights and permissions
About this article
Cite this article
A deep learning system for predicting time to progression of diabetic retinopathy. Nat Med 30, 358–359 (2024). https://doi.org/10.1038/s41591-023-02742-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02742-5
